70 results
8-K
EX-99.1
ADIL
Adial Pharmaceuticals Inc
14 Nov 23
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
5:29pm
due to reduced bonus payments and headcount.
Net Loss was $1.4 million for the three months ended September 30, 2023, compared to a net loss of $3.1
8-K
EX-99.1
rgiwoxo
26 Sep 23
Other Events
9:08pm
8-K
EX-2.3
i94vlsc3rx
21 Sep 23
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
02j eq1fsu
21 Aug 23
Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
8:46am
8-K
s913i4o 5ch
13 Sep 22
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.1
2rd ht0gh
13 Sep 22
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.1
ponak
23 Aug 22
Departure of Directors or Certain Officers
6:02am
8-K
y1yp4h3rzcog 2o8y
23 Aug 22
Departure of Directors or Certain Officers
6:02am
POS AM
2s0s7
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
POS AM
qaqvra
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm